Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome - 08/06/20
Doi : 10.1016/j.jaci.2019.12.909
Karoline Krause, MD a 
, Hanna Bonnekoh, MD a, André Ellrich, MSc a, Athanasios Tsianakas, MD b, c, Nicola Wagner, MD d, Jörg Fischer, MD e, Marcus Maurer, MD a
, Hanna Bonnekoh, MD a, André Ellrich, MSc a, Athanasios Tsianakas, MD b, c, Nicola Wagner, MD d, Jörg Fischer, MD e, Marcus Maurer, MD a a Department of Dermatology and Allergy, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
b Department of Dermatology, Universitätsklinikum Münster, Germany
c Department of Dermatology, Fachklinik Bad Bentheim, Bentheim, Germany
d Department of Dermatology, Klinikum Erlangen, Erlangen, Germany
e Department of Dermatology and Allergy, Universitätsklinik Tübingen, Tübingen, Germany
| Novartis Pharma GmbH supported this investigation. |
|
| Disclosure of potential conflict of interest: K. Krause has received grants from Novartis and Roche and payment for lectures and/or consultancies from Novartis, Roche, and SOBI outside the submitted work. N. Wagner has received a grant and payment for lectures and consultancies from Novartis outside the submitted work. M. Maurer has received institutional funding for research and honoraria for consulting and lectures from Novartis outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 145 - N° 6
P. 1681 - Giugno 2020 Ritorno al numero
Articolo precedente
- RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness
- Tanya Novak, Mark W. Hall, Douglas R. McDonald, Margaret M. Newhams, Anushay J. Mistry, Angela Panoskaltsis-Mortari, Peter M. Mourani, Laura L. Loftis, Scott L. Weiss, Keiko M. Tarquinio, Barry Markovitz, Mary E. Hartman, Adam Schwarz, Wolfgang G. Junger, Adrienne G. Randolph, PALISI Pediatric Intensive Care Influenza (PICFLU) Network Investigators, Ronald C. Sanders, Olivia K. Irby, Glenda Hefley, David Tellez, Katri Typpo, Barry Markovitz, Heidi Flori, Natalie Cvijanovich, Nick Anas, Adam Schwarz, Ofelia Vargas-Shiraishi, Anil Sapru, Patrick McQuillen, Angela Czaja, Peter Mourani, Matthew Paden, Keiko Tarquinio, Cheryl L. Stone, Juliane Bubeck Wardenburg, Neethi Pinto, Vicki Montgomery, Janice E. Sullivan, Adrienne G. Randolph, Anna A. Agan, Stephanie Ash, Anushay Mistry, Margaret Newhams, Stephen C. Kurachek, Allan Doctor, Mary Hartman, Edward Truemper, Sidharth Mahapatra, Machelle Dawson, Kate Ackerman, L. Eugene Daugherty, Ryan Nofziger, Steve Shein, Mark W. Hall, Lisa Steele, Lisa Hanson-Huber, Neal J. Thomas, Debra Spear, Julie Fitzgerald, Scott Weiss, Jenny L. Bush, Kathryn Graham, Renee Higgerson, LeeAnn Christie, Laura L. Loftis, Nancy Jaimon, Rainer Gedeit, Kathy Murkowski
- Antibody-coated microbiota in nasopharynx of healthy individuals and IVIg-treated patients with hypogammaglobulinemia
- Pedro Goncalves, Bruno Charbit, Christelle Lenoir, The Milieu Interieur Consortium, Darragh Duffy, Alain Fischer, James P. Di Santo
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?